JAMA:阿片类口服药与预期寿命的关系

2017-09-22 佚名 Medicalxpress

美国政府研究发现,阿片类药物滥用导致了死亡率的持续上升,这一想象正在削减美国人的预期寿命。从2000年到2015年,研究人员发现,美国人的平均寿命增加整体,从77岁上升到79岁。

美国政府研究发现,阿片类药物滥用导致了死亡率的持续上升,这一想象正在削减美国人的预期寿命。从2000年到2015年,研究人员发现,美国人的平均寿命增加整体,从77岁上升到79岁。

然而,吸毒过量的死亡率增加了一倍多,阿片类药物服用也使死亡率增加了两倍多,药物过量死亡的绝大部分原因是定期服用阿片类药物,其中包括海洛因,处方止痛药,如奥施康定 (羟考酮),维柯丁 (氢可酮)和可待因等。

事实上,阿片类药物正在拖累美国平均寿命不足为奇,这个问题,有一种紧迫感。可悲的是,虽然我们有药物可以治疗阿片成瘾问题,但是死亡率依然持续上升。美沙酮,丁丙诺啡和环丙甲羟二羟吗啡酮都可用于治疗阿片成瘾,并帮助抑制戒断症状和欲望。这些药物都很有效,但是使用的人却很少。

发表于《美国医学协会》杂志上的研究是基于2000年至2015年的政府重要统计数据,在那个时期的大部分时间里,美国人的平均预期寿命上升,因为心脏病和癌症等主要“杀手”的数量下降了。然而另一方面,死于阿尔茨海默病,事故,自杀和慢性肝病等疾病的人数却有上涨趋势,在研究的最后一年,美国人的平均寿命又开始下降,这归因为很多阿片类口服药的使用。

美国政府呼吁大众,关注阿片类药物成瘾的治疗。

原始出处:
DeborahDowe,MD, MPH1;,Elizabeth Arias,PhD, Kenneth Kochanek,MA, et al.Contribution of Opioid-Involved Poisoning to the Change in Life Expectancy in the United States, 2000-2015JAMA. September19, 2017;318(11):1065-1067. doi:10.1001/jama.2017.9308

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2048148, encodeId=bc21204814843, content=<a href='/topic/show?id=97549e882c9' target=_blank style='color:#2F92EE;'>#阿片类口服药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97882, encryptionId=97549e882c9, topicName=阿片类口服药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db5b227, createdName=gostraight, createdTime=Wed Dec 20 06:40:00 CST 2017, time=2017-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2060848, encodeId=fce12060848e0, content=<a href='/topic/show?id=49f63823396' target=_blank style='color:#2F92EE;'>#口服药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38233, encryptionId=49f63823396, topicName=口服药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed25376, createdName=gdsun, createdTime=Tue May 29 01:40:00 CST 2018, time=2018-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1309063, encodeId=409113090637c, content=<a href='/topic/show?id=a0179e879ac' target=_blank style='color:#2F92EE;'>#阿片类#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97879, encryptionId=a0179e879ac, topicName=阿片类)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e12358, createdName=lhlxtx, createdTime=Sun Sep 24 04:40:00 CST 2017, time=2017-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1315859, encodeId=f2ea131585938, content=<a href='/topic/show?id=bbc8100216a0' target=_blank style='color:#2F92EE;'>#预期寿命#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100216, encryptionId=bbc8100216a0, topicName=预期寿命)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba58436, createdName=马龙, createdTime=Sun Sep 24 04:40:00 CST 2017, time=2017-09-24, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2048148, encodeId=bc21204814843, content=<a href='/topic/show?id=97549e882c9' target=_blank style='color:#2F92EE;'>#阿片类口服药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97882, encryptionId=97549e882c9, topicName=阿片类口服药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db5b227, createdName=gostraight, createdTime=Wed Dec 20 06:40:00 CST 2017, time=2017-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2060848, encodeId=fce12060848e0, content=<a href='/topic/show?id=49f63823396' target=_blank style='color:#2F92EE;'>#口服药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38233, encryptionId=49f63823396, topicName=口服药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed25376, createdName=gdsun, createdTime=Tue May 29 01:40:00 CST 2018, time=2018-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1309063, encodeId=409113090637c, content=<a href='/topic/show?id=a0179e879ac' target=_blank style='color:#2F92EE;'>#阿片类#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97879, encryptionId=a0179e879ac, topicName=阿片类)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e12358, createdName=lhlxtx, createdTime=Sun Sep 24 04:40:00 CST 2017, time=2017-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1315859, encodeId=f2ea131585938, content=<a href='/topic/show?id=bbc8100216a0' target=_blank style='color:#2F92EE;'>#预期寿命#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100216, encryptionId=bbc8100216a0, topicName=预期寿命)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba58436, createdName=马龙, createdTime=Sun Sep 24 04:40:00 CST 2017, time=2017-09-24, status=1, ipAttribution=)]
    2018-05-29 gdsun
  3. [GetPortalCommentsPageByObjectIdResponse(id=2048148, encodeId=bc21204814843, content=<a href='/topic/show?id=97549e882c9' target=_blank style='color:#2F92EE;'>#阿片类口服药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97882, encryptionId=97549e882c9, topicName=阿片类口服药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db5b227, createdName=gostraight, createdTime=Wed Dec 20 06:40:00 CST 2017, time=2017-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2060848, encodeId=fce12060848e0, content=<a href='/topic/show?id=49f63823396' target=_blank style='color:#2F92EE;'>#口服药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38233, encryptionId=49f63823396, topicName=口服药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed25376, createdName=gdsun, createdTime=Tue May 29 01:40:00 CST 2018, time=2018-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1309063, encodeId=409113090637c, content=<a href='/topic/show?id=a0179e879ac' target=_blank style='color:#2F92EE;'>#阿片类#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97879, encryptionId=a0179e879ac, topicName=阿片类)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e12358, createdName=lhlxtx, createdTime=Sun Sep 24 04:40:00 CST 2017, time=2017-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1315859, encodeId=f2ea131585938, content=<a href='/topic/show?id=bbc8100216a0' target=_blank style='color:#2F92EE;'>#预期寿命#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100216, encryptionId=bbc8100216a0, topicName=预期寿命)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba58436, createdName=马龙, createdTime=Sun Sep 24 04:40:00 CST 2017, time=2017-09-24, status=1, ipAttribution=)]
    2017-09-24 lhlxtx
  4. [GetPortalCommentsPageByObjectIdResponse(id=2048148, encodeId=bc21204814843, content=<a href='/topic/show?id=97549e882c9' target=_blank style='color:#2F92EE;'>#阿片类口服药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97882, encryptionId=97549e882c9, topicName=阿片类口服药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db5b227, createdName=gostraight, createdTime=Wed Dec 20 06:40:00 CST 2017, time=2017-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2060848, encodeId=fce12060848e0, content=<a href='/topic/show?id=49f63823396' target=_blank style='color:#2F92EE;'>#口服药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38233, encryptionId=49f63823396, topicName=口服药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed25376, createdName=gdsun, createdTime=Tue May 29 01:40:00 CST 2018, time=2018-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1309063, encodeId=409113090637c, content=<a href='/topic/show?id=a0179e879ac' target=_blank style='color:#2F92EE;'>#阿片类#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97879, encryptionId=a0179e879ac, topicName=阿片类)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e12358, createdName=lhlxtx, createdTime=Sun Sep 24 04:40:00 CST 2017, time=2017-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1315859, encodeId=f2ea131585938, content=<a href='/topic/show?id=bbc8100216a0' target=_blank style='color:#2F92EE;'>#预期寿命#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100216, encryptionId=bbc8100216a0, topicName=预期寿命)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba58436, createdName=马龙, createdTime=Sun Sep 24 04:40:00 CST 2017, time=2017-09-24, status=1, ipAttribution=)]